KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) FCF Margin (2016 - 2025)

Globus Medical (GMED) has disclosed FCF Margin for 15 consecutive years, with 42.79% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 276.0% year-over-year to 42.79%, compared with a TTM value of 25.18% through Dec 2025, up 488.0%, and an annual FY2025 reading of 25.18%, up 488.0% over the prior year.
  • FCF Margin was 42.79% for Q4 2025 at Globus Medical, up from 18.81% in the prior quarter.
  • Across five years, FCF Margin topped out at 45.55% in Q4 2024 and bottomed at 1.72% in Q4 2022.
  • Average FCF Margin over 5 years is 18.64%, with a median of 16.86% recorded in 2023.
  • The sharpest move saw FCF Margin tumbled -2083bps in 2022, then skyrocketed 2875bps in 2024.
  • Year by year, FCF Margin stood at 9.14% in 2021, then crashed by -119bps to 1.72% in 2022, then skyrocketed by 1074bps to 16.79% in 2023, then skyrocketed by 171bps to 45.55% in 2024, then decreased by -6bps to 42.79% in 2025.
  • Business Quant data shows FCF Margin for GMED at 42.79% in Q4 2025, 18.81% in Q3 2025, and 9.99% in Q2 2025.